-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 AY7LCRcEYQ+d5FvW6NLHdA0XJ8u+WJLVqaZ08XtOsptnQfSb29bnt8Ow4jqN/Z1C
 COB5Kc9D8Y4hFloY+tFtkg==

<SEC-DOCUMENT>0001014865-96-000009.txt : 19960910
<SEC-HEADER>0001014865-96-000009.hdr.sgml : 19960910
ACCESSION NUMBER:		0001014865-96-000009
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19960906
SROS:			NASD

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARILLO BIOSCIENCES INC
		CENTRAL INDEX KEY:			0001014763
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				751974352
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-46755
		FILM NUMBER:		96626306

	BUSINESS ADDRESS:	
		STREET 1:		800 W 9TH AVE
		CITY:			AMARILLO
		STATE:			TX
		ZIP:			79101-3206
		BUSINESS PHONE:		8063761741

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAYASHIBARA BIOCHEMICAL LABORATORIES INC
		CENTRAL INDEX KEY:			0001021776
		STANDARD INDUSTRIAL CLASSIFICATION:	 []

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		2-3 SHIMOISHII 1-CHOME
		STREET 2:		OKAYAMA 700 JAPAN
		STATE:			M0
		BUSINESS PHONE:		81862244311

	MAIL ADDRESS:	
		STREET 1:		2-3 SHIMOISHII 1-CHOME
		STREET 2:		OKAYAMA 700 JAPAN
		STATE:			M0
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<DESCRIPTION>HAYASHIBARA BIOCHEMICAL LABORATORIES INC.'S 13G
<TEXT>


- ------------------------------

        OMB APPROVAL
- ------------------------------

OMB Number:  3235-0145
Expires:   October 31, 1994
Estimated average burden
hours per response.....14.90
- ------------------------------



                                  SCHEDULE 13G

             INFORMATION STATEMENT PURSUANT TO RULES 13d-1 and 13d-2

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934

                                (AMENDMENT NO. )*




                           AMARILLO BIOSCIENCES, INC.
                           --------------------------
                                (Name of Issuer)


                     Common Stock, par value $.01 per share
                     --------------------------------------
                         (Title of Class of Securities)


                                    02301P106
                                    ---------
                                 (CUSIP Number)





Check the following box if a fee is being paid with this  statement  [X]. (A fee
is not required only if the filing person:  (1) has a previous statement on file
reporting  beneficial  ownership  of more  than  five  percent  of the  class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7.)

* The remainder of this cover page should be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 or  otherwise  subject to the  liabilities  of that  section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).



                                page 1 of 5 pages

<PAGE>



                                  SCHEDULE 13G

CUSIP No. 02301P106                                        Page 2 of 5 Pages
          --------- 

1    NAME OF  REPORTING  PERSONS  S.S.  OR  I.R.S.  IDENTIFICATION  NO. OF ABOVE
     PERSONS

     Hayashibara Biochemical Laboratories, Inc.

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ]   (b)[ ]


3    SEC USE ONLY


4    CITIZENSHIP OR PLACE OR ORGANIZATION

     Japan


5    NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH  REPORTING  PERSON  WITH SOLE
     VOTING POWER

     1,232,856


6    NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING  PERSON WITH SHARED
     VOTING POWER

     None


7    NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH  REPORTING  PERSON  WITH SOLE
     DISPOSITIVE POWER

     1,232,856


8    NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING  PERSON WITH SHARED
     DISPOSITIVE POWER

     None


9    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,232,856


10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ]



11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     24.1%


12   TYPE OF REPORTING PERSON*

     CO

                      *SEE INSTRUCTION BEFORE FILLING OUT!




                                page 2 of 5 pages

<PAGE>



ITEM 1(A).        NAME OF ISSUER:

Amarillo Biosciences, Inc.

ITEM 1(B).        ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

800 West 9th Avenue
Amarillo, Texas  79101

ITEM 2(A).        NAME OF PERSON FILING:

This statement is being filed by Hayashibara Biochemical  Laboratories,  Inc., a
Japanese corporation ("HBL"). HBL is making the filing because it owns of record
the shares of Common Stock,  par value $.01 per share, of Amarillo  Biosciences,
Inc. reported as beneficially owned by it.

ITEM 2(B).        ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:

The principal business office of HBL is 2-3,  Shimoishii  1-chome,  Okayama 700,
Japan.

ITEM 2(C).        CITIZENSHIP:

HBL is a Japanese corporation.

ITEM 2(D).        TITLE OF CLASS OF SECURITIES:

Common Stock, par value $.01 per share, of Amarillo  Biosciences,  Inc. ("Common
Stock")

ITEM 2(E).        CUSIP NUMBER:

02301P106

ITEM 3.           IF THIS STATEMENT IS FILED  PURSUANT TO RULE 13D-1(B),  OR
                  13D-2(B), CHECK WHETHER THE PERSON IS:

Not applicable

ITEM 4.  OWNERSHIP:

         (a)      Amount Beneficially Owned:

                  1,232,856 shares

         (b)      Percent of Class:

                  24.1%

                                page 3 of 5 pages


<PAGE>

         (c)      Number of shares as to which such person has:

         (i)   sole power to vote or direct the vote:                  1,232,856
         (ii)  shared power to vote or direct the vote:                None
         (iii) sole power to dispose or direct the disposition of:     1,232,856
         (iv)  shared power to dispose or direct the disposition of:   None

ITEM 5.  OWNERSHIP OF FIVE PERCENT OR LESS OR A CLASS.

                  If this statement is being filed to report the fact that as of
the date hereof,  the reporting  person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following. [ ]

ITEM 6.  OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

                  Not applicable

ITEM 7.  IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
         SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

                  Not applicable

ITEM 8.  IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

                  Not applicable

ITEM 9.  NOTICE OF DISSOLUTION OF GROUP.

                  Not applicable.

ITEM 10.          CERTIFICATION.

                  Not applicable.



                                page 4 of 5 pages


<PAGE>


                                    SIGNATURE




                  After  reasonable  inquiry and to the best of my knowledge and
belief,  I certify  that the  information  set forth in this  statement is true,
complete and correct.




Dated:  September 5, 1996                HAYASHIBARA BIOCHEMICAL
                                           LABORATORIES, INC.


                                         By  /s/ Katsuaki Hayashibara
                                         ----------------------------
                                          Name: Katsuaki Hayashibara
                                          Title:  Director of Research and
                                                  Development




                                page 5 of 5 pages

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
